6th ERA-NET Call on Rare diseases is launched
Published on 06 December 2013
Author: Marlen Damjanovic
The Call includes the following topics:
Therapeutic approaches can include (but are not limited to):
- Cell-based therapy (e.g. somatic cell therapy, cell-based regenerative medicine, tissue engineering, therapies based on combinations of cells with scaffolds or substrates, etc.)
- Gene therapy (e.g. transfer of nucleic acids for therapeutic purposes including DNA, RNA, oligonucleotides etc.)
- Pharmacological therapy (e.g. use of chemicals or biopharmaceuticals including repurposing approaches, high throughput screening of molecules, etc.)
The following approaches and topics are excluded from the scope of the call:
- Development of new cell or animal models. The relevant cell or animal models do already need to be established for the purpose of the project
- Interventional clinical trials or any projects enrolling patients
- Therapeutic approaches concerning rare infectious diseases, rare cancers and rare adverse drug events in treatments of common disease
- Surgery or radiation therapies
The aim of the call is in compliance with the goals set by the International Rare Diseases Research Consortium (IRDiRC) which was launched in April 2011 to foster international collaboration in rare diseases research. For more information see IRDiRC website.
The proposal must be submitted via a two-stage submission process.
The deadline for submission of the pre-proposal (1st stage) Only pre-proposal is 30th January 2014 at 20:00 UTC.
The decision on selection of applications for invitation to submit the full proposal (2nd stage) will be communicated by mid of April 2014.
The deadline for submission of the full proposal is 26th May 2014 at 20:00 UTC.